Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph III BLU-285 vs Regorafenib in Pts w/ Locally Adv Unresectable/ Metastatic GIST

Protocol: OSU-18042

Full Title

An International, Multicenter, Open-label, Randomized, Phase III Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)